U.S., Feb. 7 -- ClinicalTrials.gov registry received information related to the study (NCT06812728) titled 'Neoadjuvant FOLFIRINOX and Preoperative Chemoradiotherapy for Locally Advanced Rectal Cancer Patients' on Feb. 01.
Brief Summary: A phase II clinical trial compared standard TNT (mFolfox6 and CRT) with preoperative chemoradiotherapy (CRT) with neoadjuvant chemotherapy (CT) containing mFolfirinox in patients with locally advanced rectal cancer.
Study Start Date: Jan. 25
Study Type: INTERVENTIONAL
Condition:
Rectum Cancer
Intervention:
DRUG: mFOLFIRINOX
Neoadjuvant chemotherapy
DRUG: mFolfox6
Neoadjuvant chemotherapy
Recruitment Status: RECRUITING
Sponsor: Menoufia University
Information provided by (Responsible Party): yos...